© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Dementia and Alzheimer Disease
The NeurologyLive dementia and Alzheimer disease clinical focus page provides information, podcasts, videos, and news about the latest FDA actions, clinical guideline updates, study and clinical trial findings, and interviews with physicians related to the care of patients with dementia and similar diseases, including Lewy body dementia, frontotemporal dementia, Alzheimer disease, and more.
This Week on NeurologyLive — June 21, 2021
June 21, 2021
Article
Here's what is coming soon to NeurologyLive.
Love and a Lab Coat: One Couple’s Quest to Treat Alzheimer Disease
June 20, 2021
Article
Luca Giliberto, MD, PhD, and Cristina d’Abramo, PhD, share more than a marriage: After years of research, their combined efforts to develop a passive immunotherapy for Alzheimer disease have earned them a $2 million grant from the National Institutes of Health.
Blarcamesine Exceeds Enrollment, Higher Plasma Nusinersen Leads to Meaningful Improvements, Neurodevelopmental Outcomes Unchanged by Maternal ASMs
June 19, 2021
Video
Neurology News Network for the week ending June 19, 2021.
NeurologyLive Friday 5 — June 18, 2021
June 18, 2021
Article
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 18, 2021.
Sleep Profiles May Predict Cognitive Decline in Alzheimer Disease
June 17, 2021
Article
While the relationship between sleep and cognition needs to be further studied, sleep-based interventions may be a future approach to help prevent cognitive decline.
Anti-Tau Agent Gosuranemab Fails to Show Efficacy in Phase 2 Alzheimer Study
June 17, 2021
Article
Biogen’s investigational antibody against the N-terminus of tau failed to meet any of the efficacy or exploratory end points in individuals with mild cognitive impairment or mild Alzheimer disease.
Blarcamesine Phase 2b/3 Alzheimer Study Exceeds Enrollment Goal
June 17, 2021
Article
Primary and secondary end points of the trial will assess safety and both cognitive and functional efficacy, measured through ADAS-Cog, ADCS-ADL, and CDR-SB.
Future of Treating Alzheimer Disease
June 15, 2021
Video
Drs Richard S. Isaacson and Marc E. Agronin look to the future of treating Alzheimer disease with the emphasis on early diagnosis.
Blood-Based Biomarkers for Diagnosis of Alzheimer Disease
June 15, 2021
Video
The use of blood-based biomarkers for diagnosis of Alzheimer disease in the context of the comprehensive diagnosis.
Impact of the Approval of Aducanumab on the Treatment Landscape in Alzheimer Disease
June 15, 2021
Video
Impact of the approval of aducanumab on the treatment landscape and other drugs in development for the treatment of Alzheimer disease.